DRY LIVE VACCINE AGAINST NEWCASTLE DISEASE AND METHOD OF ITS PREPARING

veterinary science, virology. SUBSTANCE: invention relates to production of biopreparations used for oral immunization against Newcastle disease in poultry. Vaccine has the dried extraembryonal fluid of culture of one of the strain of Newcastle disease virus "La-Sota", "A(b) BH",...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMOLENSKIJ V.I, MIKHAJLOV V.V, GRIGORENKO A.I, BREDIKHIN V.N, KOLOSKOV A.V, ARTEMOV V.A
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:veterinary science, virology. SUBSTANCE: invention relates to production of biopreparations used for oral immunization against Newcastle disease in poultry. Vaccine has the dried extraembryonal fluid of culture of one of the strain of Newcastle disease virus "La-Sota", "A(b) BH", "Clone- -30", "Bor-74 VGNKI" or "V-4" at titer values 2.0 x 108-1,0x1010EID50 ml-1, casein, stabilizing agent, dehydrating agent and desegregating agent. Casein provides stability of virus and protects vaccine from digestive effect of stomach juice. Among stabilizing agent vaccine has protein-carbohydrate complex (sucrose, lactose or glucose and enzymatic peptone) taken in the effective concentrations. Ion-exchange resin KB-4P-2 (size particle is from 100 to 800 mcm) used as dehydrating agent and modified aerosil is used as desegregating agent. Dry live vaccine is prepared by contact dehydration method. Hydrophobic aerosil taken in the amount from 1.0 to 2.0% by mass is applied on ion-exchange resin KB-4P-2 (size particle is 100-800 mcm) preliminarily. Under conditions of maintenance of components composition and developed regimes of preparing dry live vaccine is prepared. This vaccine protects immunized poultry from infection with the virulent strain "T-53" of Newcastle disease virus in the dose 1000 LD50 by from 80 to 100% at oral route of immunization. EFFECT: enhanced effectiveness of vaccine. 3 cl, 9 tbl, 9 ex